netFormulary Leeds Formulary NHS
Leeds Teaching Hospitals NHS Trust
Leeds and York Partnership NHS Foundation Trust
Leeds Community Healthcare NHS Trust
NHS Leeds CCG
 
 Introduction

Welcome to the Leeds Medicines Formulary

Useful Links

meandmymedicines

 Adult BNF
 Paediatric BNF
BNF Apps (iOS and Android) 

Further Medicines Management Resources

NHS Leeds Traffic Light List

Antimicrobial guidelines

Compliance with NICE technology appraisals

otcmedicines

 

 

News Feed

MHRA: Drug Safety Update (Sep 2019) Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions


MHRA: Drug Safety Update (Sep 2019) Elmiron (pentosan polysulfate sodium): rare risk of pigmentary maculopathy


MHRA: Drug Safety Update (Sep 2019) Fingolimod (Gilenya▼): increased risk of congenital malformations; new contraindication during pregnancy and in women of childbearing potential not using effective contraception


MHRA: Drug Safety Update (Aug 2019) Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping


MHRA: Drug Safety Update (Aug 2019) Carfilzomib (Kyprolis▼): reminder of risk of potentially fatal cardiac events


MHRA: Drug Safety Update (Aug 2019) Naltrexone/bupropion (Mysimba▼): risk of adverse reactions that could affect ability to drive


>>> more news

Leeds Secondary Care Links

  LTHT Injectable Medicines Guides (Medusa)
Adult IV monographs
Paediatric IV monographs     .

 


NetFormulary
   Last updated: 20/09/2019 08:43:15